SoftOx Solutions AS (SOFTX) Stock Overview

SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company in Norway. It offers disinfection products, which includes SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin; and EffectDesH, a surface disinfectant, which has a broad spectrum inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigation solutions for acute and chronic wounds to prevent and treat infections including biofilms; and SoftOx Anti-infectives, which aims to treat and remove topical infections in wounded and mucosal tissues, such as biofilms, AMR microbes, viruses, and fungi. In addition, its developing antiseptic solutions for pets and livestock, as well as humans; and inhalation solution, a novel and self-administered inhaled drug for early treatment and prevention of influenza-like illnesses. The company was incorporated in 2012 and is headquartered in Fornebu, Norway.